Lavanchy D, Fritzell B, Geudelin B, Peitrequin R, Frei P C
Division d'Immunologie et d'Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Res Virol. 1991 Sep-Oct;142(5):363-71. doi: 10.1016/0923-2516(91)90003-l.
Serum samples from individuals immunized with a pepsinized or non-pepsinized vaccine and from patients who had recovered from acute hepatitis B or who developed a chronic form of the disease, were analysed for the presence of antibody against the pre-S2 epitope of the hepatitis B virus. Anti-pre-S2 antibody was absent in all but one individual immunized with the pepsinized vaccine. Thirty-eight percent of the subjects who responded by anti-HBs production to the non-pepsinized preparation showed anti-pre-S2 antibody one year after complete vaccination. Among subjects who did not produce anti-HBs after immunization with this vaccine, 1 single individual produced anti-pre-S2 antibody. Anti-preS2 antibody was detectable after one year in 38% of the patients who recovered from acute hepatitis B, but in none of those with chronic hepatitis B. The kinetics of anti-pre-S2 antibody response to a booster injection was also analysed 1 month and 1 year after the 3rd injection and 1 month after the 4th injection of the non-pepsinized vaccine.
对用胃蛋白酶处理过或未处理过的疫苗免疫的个体以及从急性乙型肝炎康复或患慢性乙型肝炎患者的血清样本,分析了针对乙型肝炎病毒前S2表位的抗体的存在情况。在用胃蛋白酶处理过的疫苗免疫的个体中,除一人外其余均未检测到抗前S2抗体。在对未用胃蛋白酶处理的制剂产生抗-HBs反应的受试者中,38%在完全接种疫苗一年后显示出抗前S2抗体。在用该疫苗免疫后未产生抗-HBs的受试者中,有1人产生了抗前S2抗体。从急性乙型肝炎康复的患者中,38%在一年后可检测到抗前S2抗体,但慢性乙型肝炎患者中均未检测到。还分析了在第三次注射未用胃蛋白酶处理的疫苗后1个月和1年以及第四次注射后1个月对加强注射的抗前S2抗体反应动力学。